Table of Content




1. Executive Summary


2. Global Anti-Obesity Drug Market : Market Dynamics
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges 


3. Market Trends and Forecast Analysis from 2018 to 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Anti-Obesity Drug Market Trends (2018-2023) and Forecast (2024-2030)

3.3: Global Anti-Obesity Drug Market by Drug Type
3.3.1: Prescription Drugs
3.3.2: Over The Counter Drugs

3.4: Global Anti-Obesity Drug Market by Mechanism of Action
3.4.1: Acting Anti-Obesity Drugs
3.4.2: Peripherally Acting Anti-Obesity Drugs

3.5: Global Anti-Obesity Drug Market by Route of Administration
3.5.1: Oral
3.5.2: Subcutaneous

3.6: Global Anti-Obesity Drug Market by Distribution Channel
3.6.1: Hospital Pharmacies
3.6.2: Retail Pharmacies
3.6.3: Online Pharmacies



4. Market Trends and Forecast Analysis by Region from 2018 to 2030
4.1: Global Anti-Obesity Drug Market by Region
4.2: North American Anti-Obesity Drug Market
4.2.1: North American Anti-Obesity Drug Market by Drug Type: Prescription Drugs and Over The Counter Drugs
4.2.2: North American Anti-Obesity Drug Market by Distribution Channel: Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies

4.3: European Anti-Obesity Drug Market
4.3.1: European Anti-Obesity Drug Market by Drug Type: Prescription Drugs and Over The Counter Drugs
4.3.2: European Anti-Obesity Drug Market by Distribution Channel: Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies

4.4: APAC Anti-Obesity Drug Market
4.4.1: APAC Anti-Obesity Drug Market by Drug Type: Prescription Drugs and Over The Counter Drugs
4.4.2: APAC Anti-Obesity Drug Market by Distribution Channel: Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies

4.5: ROW Anti-Obesity Drug Market
4.5.1: ROW Anti-Obesity Drug Market by Drug Type: Prescription Drugs and Over The Counter Drugs
4.5.2: ROW Anti-Obesity Drug Market by Distribution Channel: Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies


5. Competitor Analysis
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis


6. Growth Opportunities and Strategic Analysis
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Anti-Obesity Drug Market by Drug Type
6.1.2: Growth Opportunities for the Global Anti-Obesity Drug Market by Mechanism of Action
6.1.3: Growth Opportunities for the Global Anti-Obesity Drug Market by Route of Administration
6.1.4: Growth Opportunities for the Global Anti-Obesity Drug Market by Distribution Channel
6.1.5: Growth Opportunities for the Global Anti-Obesity Drug Market by Region

6.2: Emerging Trends in the Global Anti-Obesity Drug Market

6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Anti-Obesity Drug Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Anti-Obesity Drug Market
6.3.4: Certification and Licensing


7. Company Profiles of Leading Players
7.1: Currax Pharmaceuticals
7.2: Pfizer
7.3: Novo Nordisk
7.4: GlaxoSmithKline
7.5: Boehringer Ingelheim
7.6: KVK Tech
7.7: CHEPLAPHARM Arzneimittel